【用戶】1m
【年級】大一上
【評論內容】(D)Lack of bronchoconstriction — Unlike aspirin and some NSAIDs, selective COX-2 inhibitors appear to have little risk of precipitating bronchospasm in patients with aspirin-induced asthmaHowever, despite the reassuring data from clinical trials, it should be noted that the manufacturers' labeling for the coxibs in the United States includes a warning that they should not be given to patients who have experienced asthma, urticaria, or allergic reactions after taking aspirin or other NSAIDs.Highly selective COX-2 inhibitors — Highly selective COX-2 inhibitors demonstrate at least a 200- to 3...
【用戶】1m
【年級】大一上
【評論內容】(D)Lack of bronchoconstriction — Unlike aspirin and some NSAIDs, selective COX-2 inhibitors appear to have little risk of precipitating bronchospasm in patients with aspirin-induced asthmaHowever, despite the reassuring data from clinical trials, it should be noted that the manufacturers' labeling for the coxibs in the United States includes a warning that they should not be given to patients who have experienced asthma, urticaria, or allergic reactions after taking aspirin or other NSAIDs.Highly selective COX-2 inhibitors — Highly selective COX-2 inhibitors demonstrate at least a 200- to 3...